62 results
DEFA14A
IMGN
Immunogen, Inc.
24 Jan 24
Additional proxy soliciting materials
4:57pm
to facilitate oversight of the process of exploring a potential business combination transaction. Following such discussion, the Company Board
8-K
IMGN
Immunogen, Inc.
24 Jan 24
Other Events
4:55pm
next considered establishing a transaction committee to facilitate oversight of the process of exploring a potential business combination transaction
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
committee to facilitate oversight of the process of exploring a potential business combination transaction. Following such discussion, the Company
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
a transaction committee to facilitate oversight of the process of exploring a potential business combination transaction. Following such discussion, the Company
DEFA14A
IMGN
Immunogen, Inc.
21 Dec 23
Additional proxy soliciting materials
3:54pm
will serve as the Integration Lead for our new Integration Management Office (IMO), for which ExCo will provide oversight. Stacy will be supported
8-K
EX-1.1
r57wob9exlkddcbo4bc6
5 May 23
Entry into a Material Definitive Agreement
5:15pm
8-K
zphsunwf
28 Dec 22
ImmunoGen Announces Susan Altschuller on FMLA Leave; Interim CFO Appointed
4:40pm
8-K
EX-99.1
wyasdmamviiyrs3hc99
28 Dec 22
ImmunoGen Announces Susan Altschuller on FMLA Leave; Interim CFO Appointed
4:40pm
8-K
EX-1.1
41atdi5u20rc9
3 Dec 21
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-10.1
z5vo8zy1zsjy2gv5808
18 Dec 20
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-10.1
0lqg fpbzmd
25 Sep 20
Entry into a Material Definitive Agreement
4:38pm